Sanitation and vaccination have significantly reduced childhood mortality and increased life expectancy, forming the foundation of modern medicine. However, microbial threats persist, including new pandemics, antibiotic-resistant microbes, and chronic diseases caused by microbial-immune system interactions.

To tackle these challenges, the McGill Interdisciplinary Initiative in Infection and Immunity (MI4) unites researchers from across campuses to innovate in Infectious Disease research. Since 2018, MI4 has invested over $40M, attracting more than $100M of follow-on funding. We support new research teams, streamline research efforts, and enable ambitious funding applications.

MI4 is committed to continuing our achievements. We foster collaboration among new investigator teams through seed fund grants. Our platform funding allows multiple researchers to share facilities, enhancing efficiency. Additionally, our co-funding support enables people to pursue peer-reviewed funding opportunities that might otherwise be out of reach.

We look forward to continuing this journey and hope you will join us in shaping MI4 to best support our community.